Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Retinal Diseases

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Retinal Diseases:

Pubmed Logo
Subinternal limiting membrane hemorrhage with perimacular fold in leukemia.
We examined whether SNJ-1945, a new orally available calpain inhibitor,...
18th November, 2009
Arch Ophthalmol. 2009 Nov;127(11):1548-50.
DOI Direct Link
[Stem cells in adult retina--current state of research, future therapeutic prospects]
The latest research reports revealed the presence of stem/progenitor cells...
18th November, 2009
Z Katedry i Zalladu Histologii i Embriologii Pomorskiej Akademii Medycznej Klin Oczna. 2009;111(7-9):253-7.
[Computer graphic display of retinal examination results. Software improving the quality of documenting fundus changes]
PURPOSE: Graphic documentation of retinal examination results in clinical...
18th November, 2009
Klinik und Poliklinik fur Augenheilkunde, Universitatsklinikum Greifswald Klin Oczna. 2009;111(7-9):199-202.
Molecular Mechanisms of Rhodopsin Retinitis Pigmentosa and the Efficacy of Pharmacological Rescue.
Variants of rhodopsin, a complex of 11-cis retinal and opsin, cause...
17th November, 2009
Department of Ophthalmology and the Charlie Mack Overstreet Laboratories J Mol Biol. 2009 Nov 10.
DOI Direct Link
A novel calpain inhibitor, SNJ-1945, reduces murine retinal cell death in vitro and in vivo.
We examined whether SNJ-1945, a new orally available calpain inhibitor,...
17th November, 2009
1 Department of Biofunctional Evaluation, Molecular Pharmacology, Gifu J Pharmacol Exp Ther. 2009 Nov 12.
DOI Direct Link

View more research publications.

Press Releases About Retinal Diseases:

BioPortfolio Logo
NVHR: New Data Finding Fewer than 1 in 5 Hepatitis C Patients Receiving Antiviral Therapy is 'Wake-Up Call' for Washington 24th November, 2009 National Viral Hepatitis Roundtable
WASHINGTON, Nov. 24 /PRNewswire-USNewswire/ -- New peer-reviewed data finding that fewer than one-fifth of the nearly 4 million Americans infected with chronic hepatitis C virus have received anti
Ligon Discovery Announces Appointment of Errol B. De Souza as Executive Chairman 23rd November, 2009 Ligon Discovery, Inc.
CAMBRIDGE, Mass., Nov. 23 /PRNewswire/ -- Ligon Discovery, Inc., which uses proprietary small molecule microarray technology to find drugs against high-value targets, today announced the appointment
Reportlinker Adds Holter Monitoring Systems - A Global Market Review 23rd November, 2009 Reportlinker
NEW YORK, Nov. 23 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Holter Monitoring Systems - A Global Market Review http://www.reportlinker
Reportlinker Adds The Market for Heart Benefit Foods (3rd Edition) 23rd November, 2009 Reportlinker
NEW YORK, Nov. 23 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. The Market for Heart Benefit Foods (3rd Edition) http://www.reportlinker
Hard To Treat Diseases (HTDS) Appoints Fred Carlini as Strategic Advisor 23rd November, 2009 Hard to Treat Diseases
Former Head of Worldwide Development for Roche Labs To Advise HTDS SHENZHEN, China, Nov. 23 /PRNewswire-FirstCall/ - HTDS www.htdsmedical.com Hard to Treat Diseases, Inc. (HTDS) announced appointment

BioNews Results for Retinal Diseases:

RSS Logo
BioPortfolio Logo
Alcon Takes On Potentias AMD Therapy and Gains Option Related to Other Retinal Diseases
Genetic Engineering News:  Oct 23 2009 8:06PM Matching: retinal diseases
Chemical Approach For Treating Retinal Degenerative Diseases
Medical News Today:  Oct 14 2009 10:49AM Matching: retinal diseases

Retinal Diseases Patents:

USPTO Logo
US Patent No.Title
7427685 Therapeutic substituted cyclopentanes
7468360 Therapeutic amides and related compounds
7470686 Method of inhibiting the expression and/or the activity of JNK
7473420 Systems and methods for treating patients with processed lipoaspirate cells
7479481 Treatment of ocular diseases and disorders using lantibiotic compositions

View more patents.

Companies working in the area of Retinal Diseases from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Pharmacyclics Incorporated

Pharmacyclics, Inc. is a pharmaceutical company developing energy-potentiating drugs to improve radiation therapy andchemotherapy of cancer, and to enable or improve the photodynamic therapy of...
www.pcyc.com/        View full profile
Thumbshot

Acucela Inc

Acucela Inc. is a biotech company discovering new drug therapies for eye diseases. Neurodegenerative retinal diseases such as macular degeneration, Stargardt's disease, retinitis pigmentosa and...
www.acucela.com/        View full profile
Thumbshot

Neurotech USA, Inc

Neurotech is a biotechnology company dedicated to the development of sight-saving therapeutics for chronic retinal diseases. Retinal diseases represent significant unmet medical needs for which new...
www.neurotechusa.com/        View full profile
Thumbshot

View more Retinal Diseases related companies.

BioPortfolio Ltd. offers e-mail and postal lists for Retinal Diseases scientists - we have details of around 1275 individuals working on Retinal Diseases .


This page has been viewed 374 times
Recent Search Terms used to find this page: retinal diseases | eye diseases retina | ny times genetic retinal disease | stargardt s disease stem cells | retina disease documentation | retinal diseases are chronic | clinic beirut | retinal diseases clinical | stem cells used in retinal diseases | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Retinal Diseases across BioPortfolio, or for Retinal Diseases Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.